B
BioRestorative Therapies D
D
BRTX
1.81000
USD
-0.16
(-7.89%)
مغلق
حجم التداول
3,784
الربح لكل سهم
-1
العائد الربحي
-
P/E
-1
حجم السوق
12,525,053
المقالات
العنوان: BioRestorative Therapies
القطاع: Healthcare
الصناعة: Biotechnology
BioRestorative Therapies Inc is a biotechnology company based in the United States. It focuses on the development of regenerative medicine products and therapies using cell and tissue protocols, primarily involving adult (non-embryonic) stem cells. The company's two core development programs include the Disc/Spine Program, which involves cell therapy candidate, BRTX-100, a product formulated from autologous cultured mesenchymal stem cells collected from the patient's bone marrow; and the Metabolic Program, which includes the development of cell-based therapy to target obesity and metabolic disorders using brown adipose-derived stem cells, to generate brown adipose tissue.